ImmuCell Corporation (ICCC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ImmuCell Corporation

    NASDAQ: ICCC · Real-Time Price · USD
    6.38
    -0.17 (-2.60%)
    At close: Oct 03, 2025, 3:59 PM
    6.52
    2.19%
    After-hours: Oct 03, 2025, 07:02 PM EDT

    ImmuCell Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 26.49M 17.47M 18.57M 19.24M
    Cost of Revenue
    		 18.55M 13.08M 10.92M 10.59M
    Gross Profit
    		 7.94M 4.4M 7.65M 8.66M
    Operating Income
    		 -1.64M -5.75M -2.3M -2.2M
    Interest Income
    		 77.7K n/a 153.1K 18.81K
    Pretax Income
    		 -2.15M -5.77M -2.49M -69K
    Net Income
    		 -2.16M -5.77M -2.49M -78K
    Selling & General & Admin
    		 5.68M 5.22M 5.45M 4.23M
    Research & Development
    		 3.9M 4.39M 4.49M 4.17M
    Other Expenses
    		 n/a 527K n/a n/a
    Operating Expenses
    		 9.58M 10.14M 9.95M 8.4M
    Interest Expense
    		 568.73K n/a 348.54K 314.36K
    Selling & Marketing Expenses
    		 3.47M 3.09M 3.19M 2.5M
    Cost & Expenses
    		 28.13M 23.22M 20.87M 18.99M
    Income Tax Expense
    		 10.06K 4.63K 8K 9K
    Shares Outstanding (Basic)
    		 8.17M 7.7M 7.75M 7.59M
    Shares Outstanding (Diluted)
    		 8.17M 7.75M 7.75M 7.59M
    EPS (Basic)
    		 -0.26 -0.75 -0.32 -0.01
    EPS (Diluted)
    		 -0.26 -0.75 -0.32 -0.01
    EBITDA
    		 1.11M -2.5M 349.99K 2.72M
    EBIT
    		 -1.58M -5.22M -2.14M 237.39K
    Depreciation & Amortization
    		 2.69M 2.72M 2.49M 2.47M

    Add to Watchlist